Cargando…

High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a devastating blood cancer with high heterogeneity and ill-fated outcome. Despite numerous advances in AML treatment, the prognosis remains poor for a significant proportion of patients. Consequently, it is necessary to accurately and comprehensively identify biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bichen, Wang, Wenjun, Li, Qiaoli, Guo, Tengxiao, Yang, Shuang, Shi, Jun, Yuan, Weiping, Chu, Yajing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355208/ https://www.ncbi.nlm.nih.gov/pubmed/37476188 http://dx.doi.org/10.7150/jca.84215

Ejemplares similares

HILI destabilizes microtubules by suppressing phosphorylation and Gigaxonin-mediated degradation of TBCB
por: Tan, Hao, et al.
Publicado: (2017)

Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia
por: Chu, Yajing, et al.
Publicado: (2019)

SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia
por: Chu, Yajing, et al.
Publicado: (2020)

PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway
por: Hou, Shuaibing, et al.
Publicado: (2023)

PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression
por: Yuan, Shengnan, et al.
Publicado: (2021)

Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE
por: Nolasco, Sofia, et al.
Publicado: (2021)

High-expression of the innate-immune related gene UNC93B1 predicts inferior outcomes in acute myeloid leukemia
por: Li, Qiaoli, et al.
Publicado: (2023)

Colony-stimulating factor 3 receptor (CSF3R) M696T mutation does not impact on clinical outcomes of a Ph+ acute lymphoblastic leukemia patient
por: Chen, Xin, et al.
Publicado: (2021)

Tubulin Folding Cofactor TBCB is a Target of the Salmonella Effector Protein SseK1
por: Araujo-Garrido, Juan Luis, et al.
Publicado: (2020)

Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway
por: Zhou, Pan, et al.
Publicado: (2019)

Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
por: Swatler, Julian, et al.
Publicado: (2021)

Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
por: Gao, Yanan, et al.
Publicado: (2016)

Identification of the immunosuppressive effect of γδ T cells correlated to bone morphogenetic protein 2 in acute myeloid leukemia
por: Liang, Shuang, et al.
Publicado: (2022)

Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia
por: Hong, Chang-Sook, et al.
Publicado: (2017)

Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes
por: Ferraro, Francesca, et al.
Publicado: (2021)

S275: PUS1 REGULATES ERYTHROPOIESIS VIA TRNA PSEUDOURIDYLATION AND CYTOPLASMIC TRANSLATION
por: Chu, Yajing, et al.
Publicado: (2023)

Loss of Tet2 affects platelet function but not coagulation in mice
por: Wang, Bichen, et al.
Publicado: (2020)

High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2017)

High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia
por: Li, Kongfei, et al.
Publicado: (2021)

Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Shi, Jin-long, et al.
Publicado: (2015)

Rapamycin Promotes the Expansion of Myeloid Cells by Increasing G-CSF Expression in Mesenchymal Stem Cells
por: Li, Minghao, et al.
Publicado: (2022)

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016)

LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia
por: Guo, Chao, et al.
Publicado: (2020)

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2022)

Acute Myeloid Leukemia with Myelodysplasia-Related Changes in a Patient with Crohn's Disease Treated with Immunosuppressive Therapy
por: Li, Bowen, et al.
Publicado: (2018)

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
por: Yang, Lan, et al.
Publicado: (2018)

High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia
por: Li, Jun, et al.
Publicado: (2021)

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
por: Eckardt, Jan-Niklas, et al.
Publicado: (2023)

R274X-mutated Phf6 increased the self-renewal and skewed T cell differentiation of hematopoietic stem cells
por: Lan, Yanjie, et al.
Publicado: (2023)

HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia
por: Zhang, Xiaoning, et al.
Publicado: (2022)

High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2016)

Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells
por: Gu, Ye, et al.
Publicado: (2017)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
por: Kaweme, Natasha Mupeta, et al.
Publicado: (2021)

Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia
por: Cortes, Jorge E., et al.
Publicado: (2020)

High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia
por: Shi, Jinlong, et al.
Publicado: (2016)

Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia
por: Wang, Peipei, et al.
Publicado: (2023)

Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
por: Chen, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_avnv37slcq02rtdvdii3f5gih9